Cefpodoxime Clavulanic Acid WFI

ODOXICEF CV DS WFI

null
COMPOSITION
Cefpodoxime50MG
Clavulanic Acid WFI31.25MG
SPECIFICATION
FORMPEDIATRIC
PACKING 30ML
PACKING TYPE
MRP88

DESCRIPTION

Cefpodoxime and Clavulanic acid combination are effective against multiple infections. The pharmacological action of Clavulanic acid prevents hydrolysis of Cefpodoxime against beta-lactamase secreting microbes and increases the antibiotic spectrum.

SIDE EFFECTS

No information available

INDICATION

Cefpodoxime and Clavulanic acid are contraindicated in patients with serious allergy to penicillin, cephalosporin group of antibiotics and renal impairment.

Important Notice:-  The Database is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

null